Pfizer Inc. (PFE) stock analysis

In our weekly check, Pfizer Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 5, red flags: 6.

About Pfizer Inc.

Pfizer Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as PFE.

What our checks show for PFE

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-02

Similar companies

NVO · GILD · BMY · SNY · AMGN · GSK

Questions

What grade does Pfizer Inc. (PFE) have?

In our weekly check, Pfizer Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 5, red flags: 6. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of PFE stock?

This week's biggest flags for Pfizer Inc.: High debt, Margins falling, Weak revenue forecast. In total 11 of 25 checks show a warning or a red flag.

What does Pfizer Inc. do?

Pfizer Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as PFE.

When does Pfizer Inc. report earnings next?

The next earnings report is expected on 2027-02-02. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis